Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Induction of allogeneic tumour- and lymphokine-activated lymphocytes against hepatocellular carcinoma.

Journal of gastroenterology and hepatology - 1 Jan 2000

Yasumura S, Higuchi K, Hioki O, Okada K, Tsukishiro T, Tsuchida T, Miyagiwa M, Nambu S, Yasuyama T, Inoue K

Abstract excerpt

For clinical application of adoptive immunotherapy against hepatocellular carcinoma (HCC), it is not easy to prepare tumour specific effector cells such as cytotoxic T lymphocytes (CTL). To induce potent and broad-spectrum effectors, allogeneic cultured hepatoma cell lines (JHH-4 and HuH-6) were used as stimulators of peripheral blood lymphocytes (PBL) instead of autologous HCC cells. Allogeneic tumour- and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Monoclonal
Share to Antigens, Differentiation

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Carcinoma, Hepatocellular

Share to Cell Line

Share to Flow Cytometry

Share to Liver Neoplasms

Share to Phenotype

Share to Tumor Cells, Cultured

Source

Identifiers

PMID: 1315167
DOI: 10.1111/j.1440-1746.1992.tb00950.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Induction of allogeneic tumour- and lymphokine-activated lymphocytes against hepatocellular carcinoma.PMID 1315167Read ↗

Suicide gene-modified killer cells as an allogeneic alternative to autologous cytokine-induced killer cell immunotherapy of hepatocellular carcinoma.Semantic proximity Read ↗

Natural killer activity of human liver-derived lymphocytes in various liver diseases.Semantic proximity Read ↗

A new in vitro model of specific targeting therapy of cancer: retargeting of PWM-LAK cells with bispecific antibodies greatly enhances cytotoxicity to hepatocellular carcinoma.Semantic proximity Read ↗

Autologous tumour-specific cytotoxic T-cell clone established from tumour-infiltrating lymphocytes (TIL) of malignant ascites in the absence of recombinant interleukin 2(rIL2): activation by autologous tumour cell alone.Semantic proximity Read ↗

Cytolytic potential of peripheral blood T-lymphocytes following adoptive immunotherapy with lymphokine-activated killer cells and low-dose interleukin 2.Semantic proximity Read ↗

A phase I study of autologous dendritic cell-based immunotherapy for patients with unresectable primary liver cancer.Semantic proximity Read ↗

Autologous tumor cell killing activity of tumor-associated lymphocytes in patients with head and neck carcinomas.Semantic proximity Read ↗

Functional and phenotypic characteristics of recombinant interleukin-2 or T-cell growth factor-activated splenic lymphoid cells from patients with gastric or hepatocellular carcinoma.Semantic proximity Read ↗

[Characterization of lymphokine-activated killer cells obtained from the natural killers--T cells of patients with hepatic tumor lesion].Semantic proximity Read ↗

Induction of human cytotoxic T lymphocytes by artificial antigen-presenting cellsSemantic proximity Read ↗

Generation of lymphokine-activated killer cells by adherent LGL phenotype cells and non-adherent T lymphocytes.Semantic proximity Read ↗

Autologous tumor-specific cytotoxic T-lymphocytes in a child with neuroblastoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.